van Houte Hans: insider trades.
van Houte Hans reported 6 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($183K), across 1 company.
- Transactions
- 6
- Purchases (P)
- 0
- Sales (S)
- 3
- Companies
- 1
- Name as filed
- van Houte Hans
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Nurix Therapeutics, Inc. (NRIX) | Officer · Chief Financial Officer | 6 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-04 | Nurix Therapeutics, Inc. | S | 1,794 | $23.89 | 43,133 | Form 4 |
| 2026-08-04 | Nurix Therapeutics, Inc. | S | 2,967 | $24.65 | 40,166 | Form 4 |
| 2026-07-30 | Nurix Therapeutics, Inc. | M | 3,750 | $0 | 41,342 | Form 4 |
| 2026-07-30 | Nurix Therapeutics, Inc. | S | 2,845 | $23.38 | 44,927 | Form 4 |
| 2026-07-30 | Nurix Therapeutics, Inc. | M | 3,572 | $0 | 47,772 | Form 4 |
| 2026-07-30 | Nurix Therapeutics, Inc. | M | 2,858 | $0 | 44,200 | Form 4 |
Questions
What stock did van Houte Hans buy or sell?
van Houte Hans reported 6 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($183K), across 1 company.
Is van Houte Hans the same person as other filers with this name?
This page covers SEC CIK 1817217 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/van-houte-hans-1817217.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.